Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Ferro-Malt |
| Active Ingredient: | Iron polymaltose 37mg/mL equivalent to elemental iron 10 mg/mL |
| Dosage Form: | Oral solution |
| New Zealand Sponsor: | AFT Pharmaceuticals Limited |
| Manufacturer: | XL Laboratories Pvt. Limited, Bhiwadi, India |
| Product: | Luxturna |
| Active Ingredient: | Voretigene neparvovec 0.05mg/mL equivalent to 5 x 10^12 vector genomes per mL |
| Dosage Form: | Concentrate for injection with diluent |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturer: | Nova Laboratories Limited, Wigston, United Kingdom |
Dated this 14th day of October 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).